The present invention relates to cooling medical patients. More specifically, this application relates to a cooling pad for treating medical patients benefiting from cooling treatment and to methods for using such a cooling pad.
There are a number of medical conditions in which systemic cooling is an effective therapy. For example, rapid systemic cooling of stroke and head-trauma patients has significant therapeutic benefits. Stroke is a major cause of death and neurological disability, but recent research has suggested that even though a stroke victim's brain cells may lose their ability to function during the stroke, they do not necessarily die quickly. Brain damage resulting from a stroke may take hours to reach maximum effect. Neurological damage may be limited and the stroke victim's outcome improved if a cooling neuroprotectant therapy is applied during that timeframe.
Similar possibilities exist with the victims of trauma such as may result from vehicle crashes, falls, and the like. Such trauma may cause brain injury through mechanisms that have overlap with elements in the genesis of neurologic damage in stroke victims. Delayed secondary injury at the cellular level after the initial head trauma event is recognized as a major contributing factor to the ultimate tissue loss that occurs after brain injury.
Cooling therapy has been shown in a number of studies to confer neuroprotection in stroke victims and may hasten neurologic recovery. Such cooling therapy may be applied with the use of a medical cooling pad that is placed on the patient. For example, the pad might be placed on the patient's torso and fluid such as water or air circulated through the pad. Thermal energy is then exchanged between the patient and the circulated fluid so that when the temperature of the fluid is lower than the desired temperature of the patient, the patient is cooled.
Embodiments of the invention provide a medical pad that comprises a plurality of layers. A first layer of the medical pad is for containing a first thermal-exchange fluid circulatable therethrough (e.g., cooled fluid circulated via an interconnected pump/heat exchange unit). The medical pad is selectively positionable to contact a patient on a first side thereof, and is operable for thermal exchange between the circulatable first thermal-exchange fluid and a patient through a first side of the first layer and the first side of the medical pad. A second layer of the medical pad may be disposed on a second side of the first layer, opposite to the first side of the first layer. The second layer encloses a second thermal-exchange fluid.
The medical pad is operable for thermal exchange between the second thermal-exchange fluid and the patient through the first side of the medical pad. In some approaches the second thermal-exchange fluid may comprise a liquid having a freezing point of 0° C. or less. In turn, in such approaches, the second thermal-exchange fluid contained in the second layer may be chilled, e.g., to at least a semi-frozen state, prior to use. Additionally, in such approaches, the second thermal-exchange fluid may comprise liquid in a gel form. For example, a gel material comprising a water/polymer matrix may be utilized. In some implementations, shape-holding gels may be utilized.
The medical pad may be configured for different levels of thermal communication with the first and second thermal-exchange fluids in different embodiments. In some embodiments, for example, greater than 30% of an area of the medical pad in contact with the patient is in thermal communication with the first thermal-exchange fluid (e.g., located adjacent thereto), and in a specific embodiment, approximately 50% of the area of the medical pad in contact with the patient is in thermal communication with the first thermal-exchange fluid (e.g., located adjacent thereto). Similarly, in other embodiments, greater than 30% of an area of the medical pad in contact with the patient is in thermal communication with the second thermal-exchange fluid (e.g., located adjacent thereto), and in a specific embodiment, approximately 50% of the area of the medical pad in contact with the patient is in thermal communication with the second thermal-exchange fluid (e.g., located adjacent thereto).
In one embodiment, approximately 50% of the area of the medical pad in contact with the patient is in thermal communication with the first thermal-exchange fluid (e.g., located adjacent thereof) and approximately 50% of the area of the medical pad in contact with the patient is in thermal communication with the second thermal-exchange fluid (e.g., located adjacent thereto).
The second layer may extend across at least a majority of a lateral extent of the first layer. Further, the second layer may comprise a plurality of chambers. In some such embodiments, the plurality of chambers may each enclose a corresponding different portion of the second thermal-exchange fluid therewithin. In some embodiments, at least a portion of each of the plurality of enclosed chambers may be located laterally adjacent (e.g., side-by-side) with corresponding first thermal-exchange fluid containment portions, e.g., fluid flow channels, of the first layer.
Each of the plurality of chambers may project away from the second side of the first layer with indentations defined therebetween. For instance, the plurality of chambers may, in one embodiment, define a waffle-shaped configuration. The provision of indentations between adjacent chambers (e.g., laterally and/or longitudinally extending indentations), together with the utilization of pliable materials to define the first and second layers, allows for a degree of pivotal, or hinge-like movement, about such indentations. Such feature facilitates medical contact with a patient and is particularly advantageous when the second thermal-exchange fluid is in a solid or semi-solid state (e.g., ice).
An adhesive surface may be disposed on the first side of the first layer and adapted for releasable adhesive contact with skin of a patient. In certain embodiments, the adhesive surface extends across at least a majority of a lateral extent of the first layer. In such embodiments, the first and second layers may also be adapted for conformal contact between the adhesive surface and the skin of the patient. For example, as indicated above, the first and second layers may be defined by pliable materials.
Ports may be fluidly interconnected to the first layer for selective interconnection to a separate pump/heat exchanger unit provided for circulation of the first thermal-exchange fluid. In such cases, a first port is fluidly interconnected to the first layer for circulating the first thermal-exchange fluid into the first layer and a second port is fluidly interconnected to the first layer for circulating the first thermal-exchange fluid out of the first layer.
Embodiments of the invention may also comprise different thermal properties for the thermal-exchange fluids. For example, at least one of the first thermal-exchange fluid or the second thermal-exchange fluid may have a thermal conductivity that exceeds 5.0 W/mK, that exceeds 10.0 W/mK, that exceeds 50.0 W/mK, that exceeds 100.0 W/mK, or that exceeds 250 W/mK in various embodiments. The at least one of the first thermal-exchange fluid or the second thermal-exchange fluid may comprise a liquid containing a material having a thermal conductivity that exceeds a thermal conductivity of the liquid by at least a factor of 10, a factor of 50, a factor of 100, a factor of 500, or a factor of 1000 in various embodiments.
Embodiments of the invention also include methods for contact cooling of a patient and for providing a medical pad for contact cooling. In the former aspect, a medical pad may be positioned on a patient. Thermal energy is transferred as part of a first transferring step between a contained layer of the medical pad and the patient. The contained layer may enclose a first thermal-exchange fluid that is chilled, e.g., to a temperature of 5° C. or less (e.g., frozen water). Thermal energy is also transferred as part of a second transferring step between a circulation layer of the medical pad and the patient by circulating a second thermal-exchange fluid through the circulation layer of the medical pad.
The first transferring step may be performed over greater than 30% of an area of the medical pad in contact with the patient, and in some cases is performed over approximately 50% of an area of the medical pad in contact with the patient. Similarly, the second transferring step may be performed over greater than 30% of an area of the medical pad in contact with the patient, and in some cases is performed over approximately 50% of the area. In one embodiment, the first transferring step is performed over approximately 50% of an area in contact with the patient and the second transferring step is performed over approximately 50% of the area.
The first and second transferring steps may be at least partially offset. For instance, the first transferring step may be initiated at a first location and the second transferring step may be initiated at a second location different from the first location. In such cases, the patient may be moved from the first location to the second location between initiation of the first transferring step and initiation of the second transferring step, such as in an ambulatory vehicle. In some embodiments, at least a portion of the first transferring step is completed during the moving step.
The method may also comprise cooling the medical pad prior to each of the positioning, first transferring, and second transferring steps. In such cases, the first thermal-exchange fluid may be chilled by such cooling to a temperature below at least 5° C. In some approaches, the first thermal-exchange fluid may be chilled to a frozen or semi-frozen state prior to positioning at the pad on a patient.
In some embodiments, the medical pad may be positioned on the patient by adhering the medical pad to skin of a bodily portion of the patient. In such embodiments, a liner may be removed from an adhesive surface of the medical pad, and the adhesive surface of the medical pad may be contacted with the skin of the bodily portion of the patient. The adhesive surface may extend across at least a majority of a lateral extent of the circulation layer. Thermal exchange may occur across the adhesive surface during the first transferring step and during the second transferring step, e.g., without displacing or otherwise repositioning the medical pad relative to the patient.
In some embodiments, the second transferring step comprises fluidly interconnecting the medical pad to a fluid control system. In such embodiments, the second thermal-exchange fluid may be circulated through the circulation layer of the medical pad and the fluid control system.
Numerous additional features and advantages of the present invention will become apparent to those skilled in the art upon consideration of the embodiment descriptions provided hereinbelow.
A further understanding of the nature and advantages of the present invention may be realized by reference to the remaining portions of the specification and the drawings wherein like reference numerals are used throughout the several drawings to refer to similar components. In some instances, a sublabel is associated with a reference numeral following a hyphen to denote one of multiple similar components. When reference is made to a reference numeral without specification to an existing sublabel, it is intended to refer to all such multiple similar components.
Embodiments of the invention provide a medical pad and methods of contact cooling a patient. The medical pad includes a plurality of layers, at least one of which is a circulation layer for containing a circulatable thermal-exchange fluid that can circulate through the layer and at least one of which is a containment layer that encloses a contained thermal-exchange fluid.
A general overview of one structure for the medical pad according to embodiments of the invention is provided with
An adhesive surface 120 may be disposed on a skin-contacting side of the circulation layer 116 for adhering the pad 100 to the skin of a patient. A removable liner 124 may be provided over the adhesive surface 120 to protect the adhesive surface 120 from contamination while the pad 100 is not in use. The removable liner 124 may be selectively removed when the pad 100 is used.
In one approach, the adhesive surface 120 may be provided as a number of downward-facing adhesive strips (e.g., peripheral strips and/or strips extending across the lateral extent of the medical pad), each having a selectively removable release liner 124 exposed thereupon. The adhesive strips may comprise a polyolefin or polyurethane film with hypoallergenic pressure-sensitive acrylate adhesive anchored to the pad 100 with a rubber-based pressure-sensitive adhesive.
In another approach, the adhesive surface 120 may be provided on a conformable, thermally conductive layer. The conformable, thermally conductive layer may comprise a first material, such as a liquid (e.g., water), suspended in a matrix defined by a second material, such as a polymer. In this regard, the liquid may preferably comprise between about 30 to 95 percent by weight of the total weight of the first and second materials. The adhesive surface and thermal transfer layers may be separately comprised of distinct materials. Alternatively, a thermally conductive layer may be comprised of a hydrogel material having sufficient adhesive properties so as to integrally provide the adhesive surface. In such approaches, the adhesive surface 120 may extend across the entirety or at least a majority of the skin-contacting side of medical pad 100.
A containment layer 104 may be interconnected with a second side of the circulation layer 116 that is opposite the skin-contacting side of the circulation layer 116. The containment layer 104 may include a plurality of chambers 108 which may be individually or collectively enclosed in some embodiments, or which may be enclosed in groups in other embodiments. Each of the chambers 108 may be defined by pliable members that project away from the second side of the circulation layer 110 and may have indentations therebetween as illustrated in the drawing (e.g., thereby defining a waffle-like configuration).
A first thermal-exchange fluid is generally used for circulation through the circulation layer 116 and a second thermal-exchange fluid is generally used for containment in the containment layer 104. As described in further detail below, the first and second thermal-exchange fluids may sometimes be the same fluid, but this is not a requirement of the invention and different thermal-exchange fluids may be used in the circulation and containment layers in different embodiments. In the later regard, in some embodiments, the second thermal-exchange fluid may comprise a liquid of a gel material, e.g., a shape-holding gel material.
The cross-sectional view of
Thermal exchange between the second thermal-exchange fluid and the patient's skin may occur between the channels 212, at those locations where structure 214 of the circulation layer 116 allows for the second thermal-exchange fluid to fill the dimples 204. In the illustrated embodiment, separate enclosed chambers 218 comprising the containment layer 104 may be defined by dimples 204 and overlying obtruded portions 216 to provide adjacent positioning and direct or near-direct thermal communication between the skin of the patient and the second thermal-exchange fluid in the containment layer 104. In various embodiments overlying obtruded portion 216 may be sized to each extend over a plurality of dimples 204 to define separate enclosed chambers for containing the second thermal-exchange fluid.
With the illustrated structure, approximately 50% of the skin-contacting side of the circulation layer 116 is provided adjacent to and thereby in direct or near-direct thermal communication with the circulation layer and approximately 50% of the skin-contacting side of the circulation layer 116 is provided adjacent to and thereby in direct or near-direct thermal communication with the containment layer. The structure may be varied in other embodiments to achieve different relative levels of thermal communication between the different layers. For example, in varying embodiments, greater than 20%, greater than 30%, greater than 40%, greater than 50%, greater than 60%, greater than 70%, or greater than 80% of the skin-contacting side of the circulation layer 116 is provided in direct or near-direct thermal communication with the first thermal-exchange fluid. In other embodiments, greater than 20%, greater than 30%, greater than 40%, greater than 50%, greater than 60%, greater than 70%, or greater than 80% of the skin-contacting side of the circulation layer 116 is provided in direct or near-direct thermal communication with the second thermal-exchange fluid.
It is noted that while the embodiment illustrated in
The level of thermal communication with the different thermal-exchange fluids may also be provided as desired with different configurations of the containment layer. This is illustrated through a comparison of
In the drawing of
The drawing illustrates the plurality of chambers 308 extending in a direction along the page, but it will be understood that the chambers 308 may also extend in a direction orthogonal to the page. In a specific embodiment in which the chambers 308 are thus provided in a generally rectangular configuration and each have substantially the same size and shape, the containment layer 304 may thus have a waffle-shaped configuration, but this is not a requirement of the invention. In other embodiments, the sizes of the chambers 308 may differ and the chambers 308 may be organized in other than a rectangular configuration, particularly as might be suitable for application to specific portions of the body or for specialized applications.
In the embodiment of
In an alternative embodiment such as illustrated in
A number of different thermal-exchange fluids may be used in different embodiments of the invention for both the first and the second thermal-exchange fluids, including gases and liquids such as water. As will be appreciated by those of skill in the art, the thermal-exchange characteristics of the pad 100 may depend on the thermal properties of the thermal-exchange fluids that are used. In particular, some embodiments make use of thermal-exchange fluids that include impurities, which may be in solid, liquid, or gaseous form, to tailor the thermal-exchange properties of the pad.
Table I indicates the thermal properties and densities of certain exemplary materials that may be used in different embodiments and of the thermal properties and densities of biological tissues that may interact thermally with the pad 100.
As noted in the table, a combination of water and a metal or other material such as those listed in the table may yield a greater thermal conductivity. If water is supplemented, for example, with 10 vol. % aluminum or graphite, its thermal conductivity increases by a factor of about 20. By mixing the substances in this way, the fluidic properties of water may advantageously be used while simultaneously increasing thermal conductivity. Although aluminum and graphite have similar thermal-conductivity, the specific-heat capacity of graphite offers additional advantages over the use of aluminum in some embodiments.
In one embodiment, a first thermal-exchange fluid may comprise a liquid such as water for circulation through the circulation layer 116. Further, the second thermal-exchange fluid may comprise liquid of a gel material. In one approach, a cellulose gel material may be utilized that is flowable into the containment layer 104 and curable to assume a shape-holding state within the containment layer 104. For example, a carboxmethyl cellulose (CMC) gel may be utilized that includes aluminum acetate to crosslink the CMC and form a shape-holding gel.
The configuration 400 includes areas 408 where dimples of the circulation layer (not shown) may be provided, e.g., as described above. Channels 412 may be defined by ribs 414, or raised portions. Fluid is circulated through the circulation layer through fluid ports that may be provided at manifold bonding sites 416 to provide access to the channels 412 within the circulation layer. The location, configuration, and orientation of the ports may be selectively established to provide various advantages. In particular, the ports may be provided to avoid patient weight from creating localized high-pressure areas on the skin by pressing the port or attached tubing against the skin of the patient. Reducing such high-pressure areas reduces the risk of causing pressure ulcers. Also, the tubing can exit off an a patient support platform (e.g., an emergency liter) without multiple turns, thereby reducing the risk of interconnected tubing buckling or kinking, which would limit fluid flow.
The ribs 414 prevent the first they mal-exchange fluid from following a path directly between the input and output ports of the circulation layer, e.g., going directly from site 416-1 to site 416-2. Instead, the first thermal-exchange fluid flows along a path such as illustrated with bold line 424. It is noted that this exemplary path is schematic; at a more detailed level, the actual paths followed by the first thermal-exchange fluid are meandering paths as dictated by the dimple structure of the layer and as explained above in connection with
Specific configurations for the fluid channels may be as described in, for example, U.S. Pat. No. 6,648,905, the entire disclosure of which is incorporated herein by reference for all purposes. For instance, a first plurality of channels within the circulation layer may be of coincidental, serpentine configuration. More particularly, each of the channels comprising the first plurality of channels may be of a generally S-shaped configuration. Such channels may be of a substantially common length, such as in embodiments where each channel has a length within about 15% of an average length as measured along their respective center paths. Similarly, the channels may also have a substantially common average width, such as in embodiments where each channel has a width within about 25% of an average of the average widths of each channel. A second plurality of channels may also be disposed in a coincidental manner and similarly have substantially common lengths and widths as defined. The structure may also include fluid staging chambers at the fluid ports to distribute fluid and normalize fluid flow through the different pluralities of channels.
Fluid may be circulated through the fluid ports 504 and 508 by an interconnectable fluid-control system module 520, such as through interconnected tubing lines. In one arrangement, the fluid-control system module 520 comprises a pump 532 for drawing fluid through the pads 100 under negative pressure, usually less than about -10 psi, although other pressures may be used in different embodiments. At least one thermal-exchange device 528 is provided for cooling the circulated fluid and a fluid reservoir 524.
A fluidic circuit diagram is shown in
The pump 630 is connected downstream via a pump inlet line 632 from the main outlet connector 616 and is preferably self-priming. A temperature sensor 634 and a pressure sensor 636 in the pump inlet line 632 measure the temperature and pressure respectively of the fluid exiting the pad 610 or pads connected with the fluid circulating system 600. Information from the pressure sensor 636 may be used in controlling the speed of the pump 630 so that generally constant negative pressure is maintained. The pump 630 is connected upstream via pump outlet lines 638 and a three-way valve 640 with both the reservoir 680 and the temperature storage module 660.
The temperature storage module 660 includes cooling elements 662 and a temperature sensor 664. The cooling elements 662 may be activated to cool fluid within the temperature storage module 660 to a desired temperature detectable by the temperature sensor 664. The temperature storage module 660 is connected via a primary temperature storage module outlet line 666 upstream from the reservoir 680 so that fluid that has been cooled to a desired temperature within the temperature storage module 660 flows therefrom to the reservoir 680 while the pump 630 is operating, i.e., pumping fluid therethrough. The three-way valve 640 may be regulated to control the proportion of fluid that flows to the reservoir 680 directly from the pump 630 and the portion of fluid that flows from the pump 630 through the temperature storage module 660 to the reservoir 680 in order to control the temperature of the fluid flowing into the pad 610. The temperature storage module 660 is also connected via a secondary temperature storage module outlet line 668 to the reservoir 680. A normally open valve 670 in the secondary temperature storage module outlet line 668 permits fluid to drain from the temperature storage module 660 to the reservoir 680 when the pump 630 is not operating.
The fluid reservoir 680 includes a level sensor 682 for detecting a level of fluid within the reservoir 680 and cooling element 684 for precooling fluid within the reservoir 680. When desirable, such as when the level sensor 682 indicates that the fluid level has fallen below a specified level, additional fluid may be added to the reservoir through a fill port 686 that is connected with the reservoir 680 by a fill line 688. Preferably, the reservoir 680 has a nonmixing inlet and outlet in order to minimize undesirable temperature variations of fluid within the reservoir. The outlet of the reservoir 680 is connected via a reservoir outlet line 690 to the main inlet connector 614. A temperature sensor 692 and a flow sensor 694 may be provided in the reservoir outline 690. The temperature sensor 692 measures the temperature of fluid provided to the pad inlets via the inlet feeder line 618. Information from the temperature sensor 692 may be used in regulating the three-way valve 640 to control the fluid temperature. Information from the flow sensor 694 and the temperature sensor 634 in the pump inlet line 632 may be used in determining the heat transfer between the patient and pads connected to the fluid circulating system 600. A drain line 696 with a normally closed two-way valve 698 is provided for draining the pads to the reservoir 680 when the cooling procedure is complete.
Other configurations may be used for the fluid circulating system 600 in alternative embodiments, examples of which are illustrated and described in commonly assigned U.S. Pat. No. 6,197,045, the entire disclosure of which is incorporated herein by reference for all purposes.
The method begins at block 704 by chilling the second thermal-exchange fluid in the containment layer of the medical pad. As previously noted, different thermal-exchange fluids may be used in different embodiments and therefore the phase-transition points of the fluid may differ in different embodiments. In some embodiments, the second thermal-exchange fluid has a freezing point equal to or less than 0° C. In those embodiments where the second thermal-exchange fluid comprises water mixed with another substance, the freezing point may be higher or lower than 0° C. In certain embodiments, the second thermal-exchange fluid may comprise a liquid such as water comprising a shape-holding gel material that may be chilled to 0° C. or less, such that the liquid is in a frozen state or at least a partially frozen state at block 704, and wherein the shape-holding gel maintains an initial configuration as the second thermal-exchange fluid warms during use.
It is also noted that chilling the second thermal-exchange fluid at block 704 may or may not involve a phase change in the fluid. For example, if the second thermal-exchange fluid is pure water, it may be chilled to a temperature on either side of its freezing point of 0° C. without deviating from the intended scope of the invention. Indeed, even if the second thermal-exchange fluid is frozen as part of the chilling at block 704, it is still considered to be a “fluid” as the term is used herein. Further, if the second thermal-exchange fluid has an evaporation point that is crossed as part of the chilling at block 704 so that it changes phase from a gas to a liquid, it is still considered to be a “fluid” as the term is used herein.
Use of the medical pad is generally expected to result in the transfer of thermal energy to the second thermal-exchange fluid, and such transfer may result in reversal of a phase change that occurs as part of the chilling at block 704. Such embodiments are also specifically intended to be within the scope of the invention.
At block 708, a patient is identified who is expected to benefit from application of a cooling therapy. The patient may be suffering from a stroke, head trauma, or other injury or disease that may be effectively treated with cooling therapy. It is specifically noted, though, that it is not a requirement of the invention that the patient be suffering from any type of disorder, whether it be an injury-caused disorder or otherwise. In some embodiments, the cooling therapy may be used as an adjunct to the application of other medical procedures, such as where a patient undergoing surgery is identified as likely to benefit from the application of cooling therapy.
The medical pad is applied to the identified patient at blocks 712 by removing a liner or plurality of liners from the adhesive layer, depending on whether the embodiments use a generally continuous adhesive layer or have a plurality of adhesive strips. In embodiments where no adhesive is used, block 712 may be omitted. At block 716, the medical pad is positioned on the patient. It is generally expected that the pad will be placed in contact with skin tissue with the adhesive being used to adhere the pad to the skin and thereby generally maintain its position on the patient during the cooling therapy. But in alternative embodiments, the pad may be positioned on other types of tissue, although such embodiments may omit the use of an adhesive.
The nature of the medical pad as described above, particularly its thermal properties, allows a transfer of thermal energy between the contained layer and the patient at block 720. The transfer results in cooling of the patient, at least locally in the area where the pad is applied and with consequent heating of the second thermal-exchange fluid.
At block 724, the patient is moved to a second location where the first thermal-exchange fluid may be circulated through the circulation layer of the medical pad at block 728. This results in thermal energy being transferred between the circulation layer and the patient at block 732. To realize fluid circulation, the medical pad may be selectively interconnected to a fluid control system. Circulation of the first thermal-exchange fluid may be achieved using the fluid control system as described in connection with
Movement of the patient at block 724 may take place in a number of different ways that reflect a variety of implementations of the invention. Such movement also combines with other aspects of the invention, particularly including the use of two thermal-exchange fluids that are used differently, to achieve numerous benefits. For example, there may be circumstances in which an appropriate fluid-control system is not available at the location where the medical pad is applied to the patient at block 716. This may occur, for instance, in emergency settings where a medical pad of the type described herein is maintained in an ambulatory vehicle for access by paramedics who do not have access to the fluid-control system at the emergency site. It may also occur in settings where a physician maintains medical pads of the type described herein at his or her office, but where the fluid-control system is maintained at a hospital. Still other settings where such circumstances may exist include clinics or nurses' offices in schools, which might maintain medical pads for use, but which lack the larger and more specialized fluid-control system equipment.
Irrespective of the particular circumstances, the combination of a containment layer and a circulation layer in a single medical pad provides a number of benefits in the treatment of conditions where cooling therapy is of value. While medical pads that include a circulation layer can provide effective cooling, the lack of ready availability of a fluid-control system at the site where the patient is first encountered risks losing time that may be critically important in preventing biological damage that could be mitigated with cooling therapy. Mere application of a cool substance such as ice is less effective for many reasons. As noted above, the second thermal-exchange fluid may be a substance that is better adapted for thermal exchange by having thermal-exchange properties that are more effective. Medical pads that include an adhesive also aid in maintaining a constant position on the patient for application of the cooling therapy. In addition, the integrated medical pad is already prepared in position on the patient for use with a fluid-control system when a location has been reached where such usage is possible. Timing for application of the cooling therapy can be critical in achieving the benefits of the therapy and the combination described herein can decisively make a difference in the level of irreversible biological damage that occurs to the patient, even preventing irreversible damage entirely in some cases.
Once the treatment has been applied, the medical pad may be removed from the patient at block 736. In conjunction with such removal, the medical pad may be disconnected from the fluid control system and disposed of.
Reference is now made to
The intermediate layer 840 and interface layer 850 may be provided to define a circulation layer therebetween, wherein a first thermal-exchange fluid may flow into and out of such circulation layer via fluid circulation lines 880a, 880b. Further, the intermediate layer 840 and containment layer 830 may be provided to define a containment layer therebetween for containing a second thermal-exchange fluid.
As will be appreciated, a second thermal-exchange fluid contained in the containment layer may be provided to cool a patient, independent from and/or in overlapping relation with the circulation of a first thermal-exchange fluid through the fluid circulation layer. Further, a first thermal-exchange fluid may be circulated through the fluid circulation layer to cool a patient, independent from and/or in overlapping relation with the patient cooling by a second thermal-exchange fluid contained within the containment layer.
In one approach, adjacent ones of the top layer 820, containment layer 830 and intermediate layer 840 may be interconnected about the peripheries thereof (e.g., via RF welding of copolymer materials comprising such layers). The interface layer 850 may be connected across a top side thereof to a bottom side of intermediate layer 840. The interface layer 850 may define an adhesive surface on a bottom side thereof for patient contact. In one approach, the fluid interface layer 850 may comprise a hydrogel material for presentation of an adhesive surface across the lateral extent of the bottom side of fluid interface layer 850 (e.g., across all or substantially all of the bottom side). For example, hydrogel materials may be utilized that comprise a polymer/water matrix marketed by AquaMed Technologies of Langhorne, Pa., U.S.A. The bottom layer 860 may comprise a removable liner, wherein the bottom layer 860 may be readily removed from the bottom adhesive surface of the interface layer 850 at the time of placement of medical pad 800 on a given patient for contact cooling (e.g., direct adhesive engagement with the skin of a patient). The adhesive surface may display a peel value at initial skin application of about 20 g/in. to 80 g/in. to facilitate fixed positioning on a patient, yet facilitate removal after use.
As illustrated in
In one approach, the chambers 832 and indentations 834 may be arranged in rows and columns to facilitate flexure of the medical pad along the indentations 834 for conformal engagement of medical pad 800 with a patient. In this regard, each of the layers 820, 830, 840 and 850 may be of a pliable construction to facilitate curvature, or flexure, along the lateral and/or longitudinal dimensions thereof By way of example, each of the layers may comprise a copolymer material such as a polyolefin material (e.g., ethylene-vinyl acetate).
Top layer 820 may be provided to define an insulative layer, or air space, between the top layer 820 and containment layer 830. In this regard, such insulative layer may surround chambers 832 to enhance thermal exchange between the second thermal-exchange fluid and a patient during use.
To further facilitate conformal positioning of medical pad 800 and/or enhanced thermal transfer between a patient and a first thermal-exchange fluid circulated through the circulation layer, the depressions 842 may be arranged in staggered rows and columns. In this regard, the depressions 834 on the top side of intermediate layer 840 provide corresponding projections on the bottom side of intermediate layer 840. In turn, tortuous flow paths around the projections may be defined within the fluid circulation layer.
In relation to the above-noted features, reference is now also made to
As may be appreciated, the inlet port 802a and outlet port 802b may extend through aligned openings in the top layer 820, containment layer 830, and intermediate layer 840 to provide fluid communication with the circulation layer defined by intermediate layer 840 and fluid interface layer 850. Further, top layer 820 may include one or more opening(s) 827 for receipt of a fill port 804 therethrough, as shown in
In relation to
In this regard, reference is now made to
Inlet port 802a is shown interconnected to a connector 882a in
For example, and as shown in
Reference is now made to
As shown in
As may be appreciated, medical pad 800 may be readily assembled and readied for use. For example, interface layer 850 may be provided with a removable layer 860 removably attached to the bottom adhesive surface of the fluid interface layer. In turn, the top side of the fluid interface layer 850 may be interconnected to a bottom side of the intermediate layer 840 with enlarged ends 805 of ports 802a and 802b positioned therebetween, and tubular portions 807 located through openings 845, 835, and 825. Such interconnection may occur subsequent to or prior to interconnection of the top layer 820, containment layer 830, and intermediate layer 840 about the peripheries thereof. As may be appreciated, the enlarged end 809 of fill port 804 may be disposed between intermediate layer 840 and containment layer, with tubular portion positioned through openings 847, 837, and 827, prior to such interconnection.
Relatedly, prior to use, the second thermal-exchange fluid may be flowed through fill port 804 into the containment layer defined by containment layer 830 and intermediate layer 840. In this regard, the second thermal-exchange fluid may be introduced in a manner so that it flows through fill port 804, depressions 842 and in between the bottom side of containment layer 830 and top side of intermediate layer 840 to fill depressions 842 and at least a portion of the chambers 832 across the lateral entirety of the containment layer.
In one example, a vacuum may be initially established in the containment layer via use of fill port 804. In turn, fill port 804 may be interconnected to a source for the second thermal-exchange fluid. In one approach, a gel material (e.g., a cellulose gel comprising CMC, water and a cross-linking material such as aluminum acetate) may be employed. The gel may be flowed into the containment layer to fill depressions 842 and at least a portion of or substantially all of the volumes of chambers 832. Plug 813 may then be retainably inserted in fill port 804. In turn, the gel material may be allowed to cure, wherein cross-linking occurs so that gel material sets to maintain a shape defined by the volume of containment layer.
In contemplated arrangements, after filling the fluid containment layer with the second thermal-exchange fluid, the medical pad 800 may be cooled. By way of example, in some embodiments, medical pad may simply be disposed in a freezer, yielding the medical pad 800 ready for use.
At the time of use, bottom layer 860 may be removed from an adhesive surface on the bottom side of the fluid interface layer 850, and the adhesive surface of medical pad 800 may be contacted with a patient to initiate patient cooling. As may be appreciated, such patient cooling provides for thermal exchange between the second thermal-exchange fluid and the patient. Such thermal exchange may occur, for example, during transport of a patient.
Further, as and when patient cooling is desired via thermal exchange between a first thermal-exchange fluid circulated through medical pad 800 and a patient, connectors 882a, 882b of fluid circulation lines 880a, 880b may be interconnected to ports 802a, 802b, and connector 884 may be interconnected to a fluid circulation control system, wherein the first thermal-exchange fluid may be circulated through circulation layer of medical pad 800 to achieve patient cooling in tandem with or independent from patient cooling via the second thermal-exchange fluid (e.g., during and after the second thermal-exchange fluid warms).
The foregoing description of the present invention has been presented for purposes of illustration and description. Furthermore, the description is not intended to limit the invention to the form disclosed herein. Consequently, variations and modifications commensurate with the above teachings, and skill and knowledge of the relevant art, are within the scope of the present invention. The embodiments described hereinabove are further intended to explain known modes of practicing the invention and to enable others skilled in the art to utilize the invention in such or other embodiments and with various modifications required by the particular application(s) or use(s) of the present invention. It is intended that the appended claims be construed to include alternative embodiments to the extent permitted by the prior art.
Having described several embodiments, it will be recognized by those of skill in the art that various modifications, alternative constructions, and equivalents may be used without departing from the spirit of the invention. Accordingly, the above description should not be taken as limiting the scope of the invention, which is defined in the following claims.
This application claims priority to U.S. Provisional Patent Application No. 61/381,840, filed Sep. 10, 2010, entitled “COOLING MEDICAL PAD,” and U.S. Provisional Patent Application No. 61/389,056, filed Oct. 1, 2010, entitled “COOLING MEDICAL PAD,” both of which applications are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
2250325 | Barnes | Jul 1941 | A |
2595328 | Bowen | May 1952 | A |
2602302 | Poux | Jul 1952 | A |
2726658 | Chessey | Dec 1955 | A |
3075529 | Young | Jan 1963 | A |
3091242 | Johnson, Jr. et al. | May 1963 | A |
3212286 | Curtis | Oct 1965 | A |
3506013 | Zdenek | Apr 1970 | A |
3734293 | Biskis | May 1973 | A |
3830676 | Elkins | Aug 1974 | A |
3867939 | Moore et al. | Feb 1975 | A |
3900035 | Welch et al. | Aug 1975 | A |
3927671 | Chittenden et al. | Dec 1975 | A |
3995621 | Fletcher et al. | Dec 1976 | A |
4092982 | Salem | Jun 1978 | A |
4108146 | Golden | Aug 1978 | A |
4114620 | Moore et al. | Sep 1978 | A |
4118946 | Tubin | Oct 1978 | A |
4149541 | Gammons et al. | Apr 1979 | A |
4154245 | Daily | May 1979 | A |
4161210 | Reid et al. | Jul 1979 | A |
4195631 | Baucom | Apr 1980 | A |
4311022 | Hall | Jan 1982 | A |
4444727 | Yanagihara et al. | Apr 1984 | A |
4508123 | Wyatt et al. | Apr 1985 | A |
4580408 | Stuebner | Apr 1986 | A |
4753241 | Brannigan et al. | Jun 1988 | A |
4834705 | Vaillancourt | May 1989 | A |
4846176 | Golden | Jul 1989 | A |
4886063 | Crews | Dec 1989 | A |
4908248 | Nakashima et al. | Mar 1990 | A |
4919134 | Streeter | Apr 1990 | A |
4962761 | Golden | Oct 1990 | A |
4981135 | Hardy | Jan 1991 | A |
4989607 | Keusch et al. | Feb 1991 | A |
5000252 | Faghri | Mar 1991 | A |
5005374 | Spitler | Apr 1991 | A |
5050596 | Walasek et al. | Sep 1991 | A |
5062414 | Grim | Nov 1991 | A |
5072875 | Zacoi | Dec 1991 | A |
5097829 | Quisenberry | Mar 1992 | A |
5111668 | Parrish et al. | May 1992 | A |
5113666 | Parrish et al. | May 1992 | A |
5133348 | Mayn | Jul 1992 | A |
5146625 | Steele et al. | Sep 1992 | A |
5190032 | Zacoi | Mar 1993 | A |
5265669 | Schneider | Nov 1993 | A |
5268022 | Garrett et al. | Dec 1993 | A |
5289695 | Parrish et al. | Mar 1994 | A |
5304213 | Berke et al. | Apr 1994 | A |
5304216 | Wallace | Apr 1994 | A |
5383919 | Kelly et al. | Jan 1995 | A |
5393462 | Avery | Feb 1995 | A |
5405366 | Fox et al. | Apr 1995 | A |
5407421 | Goldsmith | Apr 1995 | A |
5409500 | Dyrek | Apr 1995 | A |
5411541 | Bell et al. | May 1995 | A |
5423751 | Harrison et al. | Jun 1995 | A |
5456701 | Stout | Oct 1995 | A |
5466250 | Johnson, Jr. et al. | Nov 1995 | A |
5470353 | Jensen | Nov 1995 | A |
5484448 | Steele et al. | Jan 1996 | A |
5486207 | Mahawili | Jan 1996 | A |
5514169 | Dickerhoff et al. | May 1996 | A |
5545194 | Augustine | Aug 1996 | A |
5605144 | Simmons et al. | Feb 1997 | A |
5609620 | Daily | Mar 1997 | A |
5624477 | Armond | Apr 1997 | A |
5634940 | Panyard | Jun 1997 | A |
5640728 | Graebe | Jun 1997 | A |
5658325 | Augustine | Aug 1997 | A |
5662695 | Mason et al. | Sep 1997 | A |
5683439 | Jensen | Nov 1997 | A |
5733318 | Augustine | Mar 1998 | A |
5755755 | Panyard | May 1998 | A |
5806335 | Herbert et al. | Sep 1998 | A |
5837002 | Augustine et al. | Nov 1998 | A |
5840080 | Der Ovanesian | Nov 1998 | A |
5843145 | Brink | Dec 1998 | A |
5887437 | Maxim | Mar 1999 | A |
5913849 | Sundstrom et al. | Jun 1999 | A |
6010528 | Augustine et al. | Jan 2000 | A |
6019783 | Philips et al. | Feb 2000 | A |
6030412 | Klatz et al. | Feb 2000 | A |
6047106 | Salyer | Apr 2000 | A |
6074415 | Der Ovanesian | Jun 2000 | A |
6083256 | Der Ovanesian | Jul 2000 | A |
6083418 | Czarnecki et al. | Jul 2000 | A |
6117164 | Gildersleeve et al. | Sep 2000 | A |
6185744 | Poholski | Feb 2001 | B1 |
6189149 | Allen | Feb 2001 | B1 |
6197045 | Carson | Mar 2001 | B1 |
6238427 | Matta | May 2001 | B1 |
6257011 | Siman-Tov et al. | Jul 2001 | B1 |
6349560 | Maier-Laxhuber et al. | Feb 2002 | B1 |
6364937 | McMahon | Apr 2002 | B1 |
6371976 | Vrzalik et al. | Apr 2002 | B1 |
6375674 | Carson | Apr 2002 | B1 |
6389839 | Sabin | May 2002 | B1 |
6436130 | Philips et al. | Aug 2002 | B1 |
6454792 | Noda et al. | Sep 2002 | B1 |
6461379 | Carson et al. | Oct 2002 | B1 |
6463212 | Salyer | Oct 2002 | B1 |
6503297 | Lu et al. | Jan 2003 | B1 |
6508831 | Kushnir | Jan 2003 | B1 |
6508859 | Zia et al. | Jan 2003 | B1 |
6511502 | Fletcher | Jan 2003 | B2 |
6559096 | Smith et al. | May 2003 | B1 |
6584797 | Smith et al. | Jul 2003 | B1 |
6591630 | Smith et al. | Jul 2003 | B2 |
6601404 | Roderick | Aug 2003 | B1 |
6620187 | Carson et al. | Sep 2003 | B2 |
6645232 | Carson | Nov 2003 | B2 |
6669715 | Hoglund et al. | Dec 2003 | B2 |
6682525 | Lalonde et al. | Jan 2004 | B2 |
6688132 | Smith et al. | Feb 2004 | B2 |
6692518 | Carson | Feb 2004 | B2 |
6701724 | Smith et al. | Mar 2004 | B2 |
6743250 | Renfro | Jun 2004 | B2 |
6755801 | Utterberg et al. | Jun 2004 | B2 |
6755852 | Lachenbruch et al. | Jun 2004 | B2 |
6800087 | Papay et al. | Oct 2004 | B2 |
6802855 | Ellingboe et al. | Oct 2004 | B2 |
6818012 | Ellingboe | Nov 2004 | B2 |
6858068 | Smith et al. | Feb 2005 | B2 |
6878156 | Noda | Apr 2005 | B1 |
6904956 | Noel | Jun 2005 | B2 |
6909074 | Bradley | Jun 2005 | B1 |
6931875 | Allen et al. | Aug 2005 | B1 |
6960243 | Smith et al. | Nov 2005 | B1 |
6968711 | Smith et al. | Nov 2005 | B2 |
6969399 | Schock et al. | Nov 2005 | B2 |
7008445 | Lennox | Mar 2006 | B2 |
7022099 | Litzie et al. | Apr 2006 | B2 |
7052509 | Lennox et al. | May 2006 | B2 |
7055575 | Noel | Jun 2006 | B2 |
7063718 | Dobak, III | Jun 2006 | B2 |
7077858 | Fletcher et al. | Jul 2006 | B2 |
7097657 | Noda et al. | Aug 2006 | B2 |
7172586 | Dae et al. | Feb 2007 | B1 |
7240720 | Noel | Jul 2007 | B2 |
7303554 | Lalonde et al. | Dec 2007 | B2 |
7303579 | Schock et al. | Dec 2007 | B2 |
7338516 | Quincy, III et al. | Mar 2008 | B2 |
7377935 | Schock et al. | May 2008 | B2 |
7507250 | Lennox | Mar 2009 | B2 |
RE40815 | Kudaravalli et al. | Jun 2009 | E |
7547320 | Schook et al. | Jun 2009 | B2 |
RE40868 | Ryba et al. | Aug 2009 | E |
7621944 | Wilson et al. | Nov 2009 | B2 |
7621945 | Lennox et al. | Nov 2009 | B2 |
7666213 | Freedman, Jr. et al. | Feb 2010 | B2 |
7678716 | Yahiaoui et al. | Mar 2010 | B2 |
7686840 | Quincy, III et al. | Mar 2010 | B2 |
7727228 | Abboud et al. | Jun 2010 | B2 |
7731739 | Schock et al. | Jun 2010 | B2 |
7744640 | Faries et al. | Jun 2010 | B1 |
7763061 | Schorr et al. | Jul 2010 | B2 |
7771461 | Schock et al. | Aug 2010 | B2 |
7799063 | Ingram et al. | Sep 2010 | B2 |
7827815 | Carson et al. | Nov 2010 | B2 |
7896910 | Schirrmacher et al. | Mar 2011 | B2 |
8047010 | Carson et al. | Nov 2011 | B2 |
8597217 | Lowe et al. | Dec 2013 | B2 |
20030109911 | Lachenbruch et al. | Jun 2003 | A1 |
20030149461 | Johnson | Aug 2003 | A1 |
20030150232 | Brudnicki | Aug 2003 | A1 |
20040064170 | Radons et al. | Apr 2004 | A1 |
20040082886 | Timpson | Apr 2004 | A1 |
20040243122 | Auth et al. | Dec 2004 | A1 |
20050060012 | Voorhees et al. | Mar 2005 | A1 |
20050096714 | Freedman et al. | May 2005 | A1 |
20050187502 | Krempel et al. | Aug 2005 | A1 |
20050244629 | Usui et al. | Nov 2005 | A1 |
20050288749 | Lachenbruch | Dec 2005 | A1 |
20060030916 | Lennox | Feb 2006 | A1 |
20060036304 | Cordani et al. | Feb 2006 | A1 |
20060074469 | Lennox et al. | Apr 2006 | A1 |
20060124141 | Dobak, III | Jun 2006 | A1 |
20060136023 | Dobak, III | Jun 2006 | A1 |
20060161232 | Kasza et al. | Jul 2006 | A1 |
20060247744 | Nest et al. | Nov 2006 | A1 |
20060276089 | Amarasinghe et al. | Dec 2006 | A1 |
20060287697 | Lennox | Dec 2006 | A1 |
20070043409 | Brian, III et al. | Feb 2007 | A1 |
20070049997 | Fields et al. | Mar 2007 | A1 |
20070054122 | Paisner et al. | Mar 2007 | A1 |
20070225782 | Taylor | Sep 2007 | A1 |
20070270925 | Levinson | Nov 2007 | A1 |
20080027523 | Behringer et al. | Jan 2008 | A1 |
20080249524 | Dunning | Oct 2008 | A1 |
20080255644 | Carson | Oct 2008 | A1 |
20080275534 | Noel | Nov 2008 | A1 |
20090088825 | Ota | Apr 2009 | A1 |
20090099629 | Carson et al. | Apr 2009 | A1 |
20090131835 | Voorhees et al. | May 2009 | A1 |
20090177184 | Christensen et al. | Jul 2009 | A1 |
20090287283 | Biser et al. | Nov 2009 | A1 |
20090326619 | Kagan | Dec 2009 | A1 |
20100016933 | Chen et al. | Jan 2010 | A1 |
20100168825 | Barbknecht et al. | Jul 2010 | A1 |
20100198122 | Freund | Aug 2010 | A1 |
20110029051 | Ross | Feb 2011 | A1 |
20110306972 | Widenhouse et al. | Dec 2011 | A1 |
20110308781 | O'Riordan et al. | Dec 2011 | A1 |
20110313497 | McFarlane | Dec 2011 | A1 |
20120046720 | Ishizaki | Feb 2012 | A1 |
20120065715 | Carson | Mar 2012 | A1 |
20120191035 | Stephan | Jul 2012 | A1 |
20120220960 | Ruland | Aug 2012 | A1 |
20130116760 | Carson et al. | May 2013 | A1 |
20140214138 | Voorhees et al. | Jul 2014 | A1 |
20140277301 | Varga et al. | Sep 2014 | A1 |
Number | Date | Country |
---|---|---|
2204150 | Jul 2010 | TW |
PCTIL9900059 | Sep 1999 | WO |
PCTUS03010311 | Oct 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20120065715 A1 | Mar 2012 | US |
Number | Date | Country | |
---|---|---|---|
61389056 | Oct 2010 | US | |
61381840 | Sep 2010 | US |